Baixe o app para aproveitar ainda mais
Prévia do material em texto
Chronic solar ultraviolet damage associated with malignant melanoma of the skin Michael M. Schreiber, M.D.,* Thomas E. Moon, Ph.D., and Paul D. Bozzo, M.D.* Tucson, AZ A retrospective study of 226 cases of cutaneous malignant melanoma (CMM) was done to determine if patients with CMM showed evidence of chronic solar ultraviolet radiation damage, i.e., a past history of actinic keratosis (AK), basal cell carcinoma (BCC), squamous cell carcinoma (SCC) anywhere on the patient's skin, and solar elastosis (SE) at the site of a CMM. This statistical analysis consisted of 119 clinical records and 158 pathology slides after all cases of lentigo CMM were deleted. CMM showed no statistical correlation with AK, BCC, SCC, or SE. This supports the idea that it is not the chronic solar-ultraviolet radiation exposure that causes CMM. (J AM ACAD DERMATOL 10:755-759, 1984.) A retrospective study of 226 cases of cutaneous malignant melanoma (CMM) was done to deter- mine if patients with CMM show evidence of chronic solar ultraviolet radiation (UVR) damage, i .e. , a past history of actinic keratoses (AK), basal cell carcinoma (BCC), squamous cell carcinoma (SCC) anywhere on the patient's skin, and solar elastosis (SE) at the site of a CMM. The presence of these conditions would support the contention that chronic solar UVR plays a role in the patho- genesis of CMM. METHOD The 226 available clinical records and 182 available histopathology slides of the 533 CMM patients reported in our 1981 ~ study were reviewed. Previous histories of AK (118 patients), BCC (119 patients), and SCC (123 patients) were tabulated, as well as the patients' sex, age, and CMM location (one patient had metastatic CMM and was deleted from the latter part of the analy- From the Cancer Center, University of Arizona Health Sciences Center (T. E. M.). Accepted for publication Sept. 21, 1983. Reprint requests to: Dr. Michael M. Schreiber, Associated Der- matologists, P.C., 5402 E. Gr;mt Rd., Bldg. F, Tucson, AZ 85712. *Private practice, sis). The original 182 CMM histopathology slides were studied for the presence of SE coded minimal (none or barely seen, i.e., elastic fibers thickened and increased in number) (131 patients) and extensive (moderate or marked--basophilic degeneration of collagen shown as amorphous bundles of basophilic granular material) (51 patients). We found that twenty-seven patients had a diagnosis of lentigo maligna melanoma (LMM). All were from sun-exposed sites and had SE. Since LMM represents a different entity clinically, morphologically, and prog- nostically than other types of CMM, patients with a diagnosis of LMM were excluded from further analy- sis. Thus, 119 clinical records and 158 available pathology slides were included in the report. This de- creased our numbers of patients with AK (97), BCC (99), and SCC (102) from that stated above. Statistical tests of association (bivariate and mul- tivariate) were carried out using categorical data analy- sis methods. If p > 0.1, there was association; if be- tween 0.1 and 0.05, then suggestive; if less than 0.05, a significant association. RESULTS The distribution of patient characteristics (sex, age, and location), degree of SE, as well as a cross-classification of each of these factors are shown in Table l, Forty-six percent of the patients 755 756 Schreiber et al Journal of the American Academy of Dermatology Abbreviations used AK actinic keratosis BCC basal cell carcinoma CMM cutaneous malignant melanoma HNAH head, neck, arm, hand LF legs, feet LMM lentigo maligna melanoma SCC squamous cell carcinoma SE solar elastosis TB trunk, buttock UVR ultraviolet radiation were male. Their age distribution indicated that 39% were <50 years of age, while 37% were _>60. Also, 42% of the patients had their CMM located on the head, neck, arm, or hand area (HNAH). Patient sex and CMM location are sig- nificantly associated (p = 0.006). Male patients had a slightly higher frequency of HNAH (45%) as contrasted to female patients (39%). However, there was a marked difference in distribution by sex for trunk location (male, 47%, versus female, 29%) and for leg and foot melanoma locations (male, 8%, versus female, 32%). Patient age was also associated with CMM location (p = 0.004), older patients having a higher frequency on the HNAH while younger patients had a higher fre- quency of trunk melanoma, with approximately the same frequency of leg or foot melanoma. Pa- tient sex is not associated with patient's age (p = 0,31). The distribution of the extent of SE is shown in Table II. Only 23% (36/158) of patients with pathology slides available had extensive SE ap- parent. While patient sex was not associated with SE (p = 1.00), extent of SE was significantly as- sociated with patient age (p = 0.001), with older patients having over twice the occurrence of ex- tensive SE as compared to younger patients. In addition, the extent of SE was also significantly associated with locations of CMM (p < 0.0001); 44% of patients with CMM located on the HNAH had extensive SE, contrasted to only 2% of pa- tients with CMM located on the trunk and 13% of patients with CMM on the leg or foot. The association of AK with patient characteris- tics is shown in Table II. Forty-seven percent of the 119 patients with available information had documented prior AK. Patient age was sig- nificantly associated with the occurrence of AK, with older patients (69%) having a higher fre- quency as contrasted to younger patients (34%, p = 0.001). Although AK was reported in 56% of male and 38% of female patients, this trend was not significantly different (p = 0.106). CMM lo- cation was not associated with occurrence of AK (p = 0.23). SE had a highly significant association with prior AK (p = 0.009). Of the thirty-six patients with no prior AK, 8% had extensive SE while 33% of the thirty-six patients with prior AK had extensive SE. In addition, a significant association between AK and SE is not in any way changed when other patient characteristics are simulta- neously considered using multivariate statistical analysis (p = 0.01). Finally, the column with the heading (SE/AK) indicates that there was not a disproportionate number of patients with infor- mation on the prior AK history that also had a pathology slide available for review of their extent of SE. Table II shows the association of prior BCC with patient characteristics. Ninety-nine patients were avaiIable for inclusion in this table. Thirty- four percent (34/99) had a prior history of BCC. Age was significantly associated with BCC, older patients having a higher frequency (58%) than younger patients (21%, p < 0.001). Prior BCC is also associated with patient sex, male patients hav- ing a higher frequency (46%) than female patients (21%, p = 0.01). CMM location was not associ- ated with prior BCC (p = 0.52). SE was significantly associated with prior BCC (p = 0.02). Fourteen percent (6/44) of the patients without a prior history of BCC had extensive SE as contrasted to 33% (10/34) of patients with a history of prior BCC. This association persisted even after other patient characteristics were simul- taneously considered (p = 0.04). The association of SCC with patient charac- teristics is shown in Table II. Information was available for 102 patients, of whom eighteen had a history of prior SCC. Neither patient age, sex, or Volume I0 Number 5, Part 1 May, 1984 Chronic solar damage associated with malignant melanoma 757 Tab le I. Melanoma patient characteristics* I Male (%) Female (%) ]_ .<60yr (%) [ >60yr (%) Male 61 (48) 31 (42) HNAH Female 65 (52) 42 (58) TBLFLF Total 126 (100) 73 (100) Total (Sex/Age: NA p = 0.306) 41 (45) 42 (39) 46 (37) 37 (51) 44 (47) 31 (29) 55 (44) 20 (27) 7 (8) 34 (32) 25 (20) 16 (22) 92 (100) 107 (100) 126 (101) 73 (100) (Loc/Sex: A p = 0,006) (Loe/Age: A p = 0.004) A: Associated; Loc: location; NA: not associated. *See abbreviations table at beginning of article for abbreviations not listed. Tab le 1I. Association of melanoma patients with history of SE, AK, BCC, SCC with patient characteristics and SE* SE (%) min ext Present 36 (23) 46 (47) None 122 (77) 51 (53) Total 158 97 Male 56 16 (22) 28/50 (56) Female 66 20 (23) (SE/Sex: NAp = 1) <60 yr 82 13 (14) HNAH TB LF SE + AK (%) SE + BCC (%) SE + SCC (%) 34 (34) 18 (20) 65 (66) 84 (80) 99 102 24/52 (46) 11/51 (22) 18/47 (38) 10/47 (21) 7/51 (14) (AK/Sex: NAp = 0,106) (BCC/Sex: A p = 0.01) (SCC/Sex: NAp = 0.32) 21/61 (34) 13/63 (21) 8/63 (13) SE ext >60 yr 40 13 (37) 25/36 (69) 21/36 (58) 10/39 (26) (SE/Age: A p = 0.001) (AK/Age: A p = 0.001) (BCC/Age: A p < 0.001) (SCC/Age: NAp = 0.116) 40 31 (44) 25/46 (54) I8/47 (38) 9/48 (19) 55 l (2) 14/34 (41) 12/35 (34) 5/34 (15) 27 4 (13) 7/14 (41) 4/17 (24) 4/20 (20) (SE/Loc: A p < 0.0001)(AK/Loc: NAp = 0.23) (BCC/Loc: NAp = 0.52) (SCC/Loc: NAp = 0.583) 12/36 (46) 10/30 (33) 5/18 (28) tot = 72 tot = 74 tot = 77 (AK/SE: A p = 0.009) (BCC/SE: A p = 0.02) (SCC/SE: NA p = 0.53) Multivariate analysis AK/SE: A p = 0.01 BCC/SE: A p = 0.037 SCC/SE: NA p = 0.41 A: Associated; ext: large amorphous bundles basophilic collagen; Loc: location; min: no elastic fibers/incr, number thick fibers; NA: not associated. *See abbreviations table at beginning of article for abbreviations not listed. location of melanoma was associated with prior history of SCC (all p values >-0.12). Prior SCC was not significantly associated with SE (p = 0.53). This lack of association persisted even after the multivariate analysis was carried out adjusting for the effects of other patient charac- teristics (p = 0.41). Table III focuses on patients only with CMM located on the HNAH. Forty-nine percent of the patients were male and 45% were over the age of 60. As previously reported during our discussion of Table II, 44% of patients with HNAH CMM had extensive SE. While patient sex was not as- sociated with SE (p = 0.45), patient age was sig- nificantly associated with SE (p = 0.004). Table III shows the association of AK with pa- tient characteristics. Fifty-four percent (25/46) of patients included in this table had a prior history of AK. There continues to be a significant associa- tion between patient age and occurrence of AK (p = 0.001). Also, patient sex continues not to be associated with AK (p = 0.39). In addition, there 758 Schreiber et al Journal of the American Academy of Dermatology Table HI. Association of HNAH melanoma patients with history of SE, AK, BCC, SCC with patient characteristics and SE* sE (%) min ext SE + AK (%) Present -- 31 (44) 25 (46) 18 (38) 9 (19) None 40 (56) -- 21 (54) 29 (62) 39 (81) Total 71 46 47 48 Male 17 16 (48) 15/24 (63) 13/25 (52) 5/25 (20) Female 23 15 (38) 10/22 (45) 5/22 (23) 4/23 (17) (SE/Sex: NAp = 0.365) (AK/Sex: NAp = 0.39) (BCC/Sex: B p = 0.07) (SCC/Sex: NAp = 1) <60 yr 28 11 (28) 10/27 (37) 6/28 (21) 3/28 (11) >60 yr 12 20 (63) 15/19 (79) 12/19 (63) 6/20 (30) (SE/Age: A p = 0.004) (AK/Age: A p -- 0.001) (BCC/Age: A p = 0.009) (SCC/Age: NAp = 0.152) 12/20 (60) 10/16 (63) 4/9 (64) tot = 39 tot = 40 tOt = 41 (AK/SE: A p = 0.009) (BCC/SE: A p = 0.008) (SCC/SE: NA p = 1) SE ext Multivariate analysis SE + BCC (%) SE + SCC (%) A: Associated; B: borderline; ext: large amorphous bundles basophilic collagen; rain: no elastic fibers/incr, number thick fibers; NA: not associated. *See abbreviations table at beginning of article for abbreviations not listed. continues to be a highly significant association be- tween history of AK and extent of SE (p = 0.009). Note that 60% (12/20) of the HNAH patients with a history of AK had extensive SE. The association of BCC with patient charac- teristics for this selected population is shown in Table III. Similar distributions (as compared to Table II) are obtained for BCC distribution, with 38% of patients having a history of prior BCC. There was a significant association between pa- tient age and history of BCC (p = 0.004), as well as an association between patient sex and history of BCC (p = 0.04). The association of history of BCC with patient age as well as with patient sex is similar, as observed in Table II. A higher fre- quency was seen in male patients, as well as in those over 60 years of age. Also, there continues to be a significant association between history of BCC and extent of SE (p = 0.008). Note that 63% of patients with a history of BCC also had exten- sive SE. Table III shows the association of SCC with patient characteristics. As before (see Table II), there are similar distributions for extent of SCC, with 19% of patients having a documented SCC. Also consistent, history of SCC was not associated with patient age (p = 0.15) and not associated with patient sex (p = 0.10). In addition, history of SCC was not associated with SE (p --- 1.00). DISCUSSION There is presumptive evidence that chronic solar UVR is a carcinogen or co-carcinogen in the etiology of CMM. This is supported by the follow- ing: (1) increased incidence of CMM in areas closer to the equator1; (2) CMM patients usually have a history of painful sunburning; (3) CMM patients have a poor tanning ability ~'3 and inci- dence of CMM is inversely related to degree of skin pigmentation; (4) CMM rarely occurs on in- frequently sun-exposed sites (breast, genitalia); (5) increased incidence of CMM in recent de- cades, probably because of more leisure time spent in the sun and change in dress; (6) CMM occurs at a very young age in patients with xeroderma pigmentosum who lack the ability to repair UVR-induced deoxyribonucleic acid (DNA) damage; (7) increased incidence of CMM follow- ing periods of maximum sunspot activity4'5; (8) UVB radiation enhances melanocyte mitoses6; (9) increased incidence of CMM in summer monthsT; (10) susceptible people living in sunny climates all of their lives have a higher incidence of CMM than people recently moved to the area. s Volume 10 Number 5, Part I May, 1984 Chronic solar damage associated with malignant melanoma 759 Data not supporting chronic solar UVR as a casual agent in CMM production are: (1) less than 25% of CMM occur on the head and neck (areas of chronic sun exposure) whereas 90% of non- melanoma skin cancers occur in these areas; (2) a high incidence on the back, a nonhabitually sun- exposed area; (3) occurrence of CMMon the trunk and extremities at younger ages; (4) a large num- ber of CMM occur in office workers as compared to outdoor workers. 9-11 It is an accepted idea that most all non- melanoma skin cancers (SCC, BCC) are caused by solar UVR. They occur most commonly on sun- exposed sites and in the older population. These habitually sun-exposed sites show a marked in- crease in elastic fibers leading to SE, the earliest indicator of actinic damage.12,1~ For these reasons, we used the presence of SE, BCC, SCC, and AK as indicators of chronic actinic damage to the skin. The patient distributions and associations ob- served in Tables I and II for all patients included in this analysis are very similar to the distributions and associations observed in Table III that include only those patients with CMM located on the HNAH areas. This further implies that the location of the patient's CMM does not influence the asso- ciationof SE with other patients' characteristics and the association of SE with patient's prior his- tory of AK or skin cancer. The associations of SE with age and Iocation, of AK with age and SE, of BCC with age, sex, and SE are all as expected because AK, SE, and BCC are the result of chronic UVR damage. It was surprising that a prior history of SCC showed no statistical association with age, location, or SE; this may be in part due to the small number of patients with SCC found in this study. In conclusion, we feel that UVR plays some role in the production of CMM, but the relation- ship is certainly not clear. Perhaps, as suggested, the frequency of CMM has a relationship to the number of melanocytes at the site of occurrence, 14 and the sites of chronic sun exposure are protected by the tanned and thickened skin. Possibly it is the short, occasional, intense exposure to solar UVR on untanned skin that triggers the majority of CMM. However, the precise role of solar UVR in the pathogenesis of CMM is still unknown. REFERENCES 1. Schreiber MM, Bozzo PD, Moon TE: Malignant mela- noma in southern Arizona. Arch Dermatol 117:6-11, 1981. 2. Beitner H, Ringborg U, Wennersten G, et al: Further evidence for increased light sensitivity in patients with malignant melanoma. Br J Dermatol 104:289-294, 1980. 3. Smith PJ, Greene MH, Devlin DA, et al: Abnormal sen- sitivity to UV-radiation in cultured skin fibroblasts from patients with hereditary cutaneous malignant melanoma and dysplastic nevus syndrome. Int J Cancer 30:39-45, 1982. 4. Viola MM, Houghton A, Munster EW: Increased malig- nant melanoma following periods of maximum sunspot activity. Med Hypotheses 5:153-160, 1979. 5. Houghton A, Muster EW, Viola MV: Increased inci- dence of malignant melanoma after peaks of sunspot ac- tivity. Lancet 1:759-760, 1978. 6. Rosedahl JK, Szabo G: Mitotic activity of epidermal melanocytes in ultraviolet irradiated mouse skin. J Invest Dermatol 70:143-148, 1978. 7. Hinds MW, Lee J, Kolonel LN: Seasonal patterns of skin melanoma incidence in Hawaii. Am J Pub Health 71: 496-499, 1981. 8. Moushovitz M, Modan B: Role of sun exposure in the etiology of malignant melanoma. J Natl Cancer Inst 51:777-779, 1977. 9, Bernal V, Robinson N: The relationship of malignant melanoma, basal and squamous cell cancers to indoor and outdoor work. Br J Cancer 44:866-891, 1981. 10. Granstein RD, Sober AJ: Current concepts in ultraviolet carcinogenesis. Proc Soc Exp BioI Med 170:115-125, 1982. 11. Lee JAH: Current evidence about the causes of malignant melanoma. Prog Clin Cancer 6:151-161, 1975. 12. Kligman AM: Early destructive effects of sunlight on human skin. JAMA 210:2377-2380, 1969. 13. Knox JM, Cockerell EG, Freeman RG: Etiologic factors of premature aging. JAMA 179:630-636, I962. 14. Crombie IK: Distribution of malignant melanoma on the body surface. Br J Cancer 43:842-849, 1981.
Compartilhar